HistoryIn 1967 immunoglobulin E, IgE, was discovered by two separate research teams; one in Denver, Colorado, US, led by Kimishige and Teruko Ishizaka, and the other in Uppsala, Sweden, by S.G.O. Johansson, Hans Bennich and Leif Wide.
PhARF (Phadia Allergy Research Forum) was established by Pharmacia Diagnostics (later Phadia and now Thermo Fisher Scientific, ImmunoDiagnostics) in 1987 to honor the 20th anniversary of this discovery. Today PhARF is a collaboration between Uppsala University and Thermo Fisher Scientific, ImmunoDiagnostics.
ObjectiveThe objective of PhARF is to encourage progress in allergy research by means of an international Award. Currently the Award amounts to USD 50,000. Every year a young investigator (maximum 45 years), who has made outstanding contributions to the field of allergy is recognize by this Award. The Award is a personal prize.
Election procedureSince the Award 2009 a two-step procedure is used. First a Nomination Committee, comprised of representatives from Uppsala University, sifts out five top candidates of all nominees. Then a Scientific Committee, comprised of the Presidents of EAACI, AAAAI and WAO, together with a representative from Uppsala University, meets once a year to select the winner out of these five nominees.
Basis for electionThe candidate’s research should be of high quality and in the forefront. The research should have contributed to a better understanding of allergic inflammation as well as improved diagnostic procedures and treatment, enabling more optimal patient management. The level of independency and professional implication of the Award on the candidate’s career, will also be taken into consideration.
Recognition of the winnerThe winner (and receiver of Honorable Mentions, if any) is recognized at the yearly EAACI congress in June and invited to Uppsala University in the Autumn every year.
- PhARF Award 2015
- PhARF Award 2016
Marie Lantz, e-mail: email@example.com
Last updated 07 October 2016